NASDAQ:CADX (CADX) (CADX) Stock Price, News & Analysis → Move Your Money Before May 1 (From Stansberry Research) (Ad) Free CADX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (CADX) alerts: Email Address Ad Stansberry ResearchMove Your Money Before May 1Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? Click here to get the full story before May 1. About (CADX) Stock (NASDAQ:CADX)Cadence Pharmaceuticals, Inc. (Cadence) is a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing products principally for use in the hospital setting. The Company has rights to one product, OFIRMEV (acetaminophen) injection, an intravenous (IV), formulation of acetaminophen. The Company in-licensed the United States, and Canadian rights to OFIRMEV from Bristol-Myers Squibb Company (BMS), which sells intravenous acetaminophen in Europe and other markets for the treatment of acute pain and fever under the brand name Perfalgan. In March 2014, Mallinckrodt Plc acquired Cadence Pharmaceuticals, Inc. In March 2014, Mallinckrodt Plc completed the acquisition of Cadence Pharmaceuticals.Read More Ad Stansberry ResearchMove Your Money Before May 1Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? Click here to get the full story before May 1. CADX Stock News HeadlinesApril 25, 2024 | finance.yahoo.comMedian Technologies Reports Full-year 2023 Financial Results and Provides First Quarter 2024 Financial InformationApril 16, 2024 | finance.yahoo.comNUH LAUNCHES NEW DIGESTIVE CENTRE TO PUSH NEW FRONTIERS IN EARLY CANCER DETECTION AND CARE EXCELLENCEApril 26, 2024 | Stansberry Research (Ad)Move Your Money Before May 1Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? March 26, 2024 | tmcnet.comAvicenna.AI secures FDA clearance for two healthcare AI solutionsMarch 1, 2024 | uk.finance.yahoo.comQ4 2023 Xometry Inc Earnings CallFebruary 26, 2024 | finance.yahoo.comMedian Technologies to Participate and Speak at the 2024 European Congress of Radiology (ECR), February 28 – March 3, Vienna, AustriaJanuary 29, 2024 | finanznachrichten.deMedian Technologies Reports 2023 Revenue and Summarizes 2024 Strategic OutlookJanuary 17, 2024 | finance.yahoo.comMedian Technologies Reports Excellent Results from Its Independent Verification StudyApril 26, 2024 | Stansberry Research (Ad)Move Your Money Before May 1Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? January 16, 2024 | markets.businessinsider.comBlackford and Bot Image Announce Partnership to Enhance Prostate Cancer CareOctober 19, 2023 | finance.yahoo.comMedian Technologies Reports 2023 Half-year Results and Business Indicators for the Third Quarter of 2023October 16, 2023 | usatoday.comBest unsecured credit cards for bad credit of October 2023July 22, 2023 | usatoday.comAre your credit card rewards in jeopardy under proposed legislation?July 12, 2023 | finance.yahoo.comMedian Technologies Reports Its Business Activity for the First Half of 2023 and Announces the First Step of Its Refinancing PlanJune 15, 2023 | msn.comHow a good dog helped Daytona Beach veteran with PTSD to become a better husband, fatherJune 6, 2023 | msn.comWalkers commits to one of biggest crisp factories in the world with £58m investmentJune 5, 2023 | msn.comMoneybagg Yo Balances Pain and Pleasure on ‘Hard To Love’June 5, 2023 | msn.comNFL teams that have never won a Super BowlMay 17, 2023 | marketwatch.comComputer Aided Diagnostics (CADx) Market Size and Trend Analysis 2023-2031 by Absolute Reports with [115 Pages] in Medical Devices SectorApril 24, 2023 | benzinga.comEndoscopy Devices Market Will Attain USD 42.8 Bn Valuation by 2028 with CAGR of 3.8%: Exclusive Study by TMRApril 22, 2023 | marketwatch.comComputer Aided Diagnostics (CADx) Market Report Offers CAGR Status and SWOT AnalysisApril 21, 2023 | marketwatch.comSapphire Substrates Market Size and Share: Opportunities and Threats 2030April 8, 2023 | msn.comBreath of the Wild: Saas Ko'sah Shrine Guide (Hyrule Castle Shrine)March 14, 2023 | msn.comNo, you’re not dreaming: Amazon’s offering unbelievable discounts on everything you need for a good night’s sleepMarch 8, 2023 | marketwatch.comGrowth Analysis on Computer Aided Diagnostics (CADx) Market Size 2023-2028 with Market Dynamic and Trends | Research Report by Absolute ReportsMarch 3, 2023 | msn.comHere's what the judge who sentenced Alex Murdaugh saidFebruary 7, 2023 | msn.comTeenager dies after being hit by snowplow at Laval shopping centreSee More Headlines Receive CADX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (CADX) and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryPharmaceuticals Current SymbolNASDAQ:CADX CUSIP12738T10 CIK1333248 Webwww.cadencepharm.com Phone+1-858-4361400FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report CADX Stock Analysis - Frequently Asked Questions What other stocks do shareholders of (CADX) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (CADX) investors own include Albireo Pharma (ALBO), Agenus (AGEN), Aeterna Zentaris (AEZS), Authentidate (ADAT), Acasti Pharma (ACST), Axcelis Technologies (ACLS), Achillion Pharmaceuticals (ACHN), Atlantic Coast Financial (ACFC), Acer Therapeutics (ACER) and ARCA biopharma (ABIO). This page (NASDAQ:CADX) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (CADX) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
